PosterHIVINTEREST 2020“One Size Does Not Fit All” – Views by Stakeholders, Men on ART and Men in Communities on Improving Men’s Access to and Continued Engagement in ART in MalawiView Poster
PosterHIVINTEREST 2020Improving Viral Load Suppression Rates Among HIV Positive Children on ART in a Large Volume HIV Clinic in Western Uganda.View Poster
PosterHIVINTEREST 2020Prevalence and Factors Associated With Delayed Antiretroviral Therapy Switching at Rural Public Health Facilities in Kiboga District, UgandaView Poster
PosterHIVINTEREST 2020Low Baseline-Resistance to Integrase Inhibitors in Cameroon: Implications in the Era of Dolutegravir-based Regimens in Sub-Saharan AfricaView Poster
PosterHIVINTEREST 2020Where Are the Men in Gaza? A Cross-Sectional Study to Understand the Residency Patterns of Male Partners of Women Accessing HIV Services in Gaza, MozambiqueView Poster
PosterHIVINTEREST 2020Zimbabwe’s National Third-Line Antiretroviral Therapy Program: Cohort Description and Treatment OutcomesView Poster
PosterHIVINTEREST 20204-in-1 Granules for HIV Treatment in Children: LOLIPOP Study Interim Analysis ResultsView Poster
PosterHIVINTEREST 2020Durability of Second-Line Anti-Retroviral Therapy and Predictors of a Viral Rebound Among HIV Patients on Second-Line ART in an HIV Specialist Clinic in Uganda: A 10-Year Retrospective CohortView Poster
PosterHIVINTEREST 2020Prevalence of Drug Resistance Mutations Among HIV Positive Individuals With Low Level Viremia on Antiretroviral Therapy in BotswanaView Poster
PosterHIVINTEREST 2020Acceptability of Quadrimune, a New Abacavir/Lamivudine/Lopinavir/Ritonavir Paediatric Fixed Dose CombinationView Poster
PosterHIVINTEREST 2020Minimal Cross-Resistance to Tenofovir in Children and Adolescents Failing Abacavir-Based ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment.View Poster
PosterHIVINTEREST 2020"You Are Not Benefiting Us by Keeping Us Away": Why Do Some Eligible People on Antiretroviral Therapy (ART) Decline to Participate in Ethiopia's Appointment Spacing Model With 6-Month ART Dispensing?View Poster